NYSE:CLColgate-Palmolive Stock Price, Forecast & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CL stock has increased by 10.2% and is now trading at $75.96.
View which stocks have been most impacted by COVID-19.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings results on Friday, July, 31st. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.69 by $0.05. The company had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The business's revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.72 earnings per share.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive declared a quarterly dividend on Thursday, June 11th. Stockholders of record on Monday, July 20th will be paid a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Friday, July 17th.
View Colgate-Palmolive's dividend history.

13 Wall Street analysts have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $88.00. On average, they expect Colgate-Palmolive's stock price to reach $75.82 in the next year. This suggests that the stock has a possible downside of 0.2%.
View analysts' price targets for Colgate-Palmolive.

News stories about CL stock have been trending extremely negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Colgate-Palmolive earned a coverage optimism score of -4.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
View the latest news about Colgate-Palmolive.

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Intel (INTC), Mcdonald's (MCD) and Walmart (WMT).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (2.09%), First Eagle Investment Management LLC (1.46%), California Public Employees Retirement System (0.56%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.40%) and Sarasin & Partners LLP (0.39%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, AJO LP, Bank of New York Mellon Corp, ProShare Advisors LLC, Mondrian Investment Partners LTD, Victory Capital Management Inc., Bank of Nova Scotia, and Prudential PLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran.
View insider buying and selling activity for Colgate-Palmolive.

CL stock was purchased by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Conning Inc., Sarasin & Partners LLP, CIBC Asset Management Inc, Prio Wealth Limited Partnership, California Public Employees Retirement System, LGT Capital Partners LTD., and Ensign Peak Advisors Inc.
View insider buying and selling activity for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $75.96.

Colgate-Palmolive has a market capitalization of $65.13 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]